財務情報
- Market Capitalization 8.82 B
- Employee 673
- Founded 1997
- CEO Robert I. Blum | Robert I. Blum
- Website www.cytokinetics.com
- Headquarter California, United States
- FIGI BBG000F0R4N9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-9.72
売上高対価格比率
0.09
関連ティッカー
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 949 | KYMR Kymera Therapeutics, Inc. - Common Stock | 106.83 USD | +0.14% | +0.29% | -5.51% | +80.76% | 8.88 B USD | ||
| 952 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 136.28 USD | -1.60% | -2.36% | -5.49% | +81.39% | 8.82 B USD | ||
| 971 | AXSM Axsome Therapeutics, Inc. - Common Stock | 162.22 USD | +3.77% | -4.63% | -20.75% | +24.59% | 8.50 B USD | ||
| 985 | TGTX TG Therapeutics, Inc. - Common Stock | 54.37 USD | +0.06% | +1.93% | +2.35% | +55.65% | 8.32 B USD |